Pathological issues in biopsy specimens of men with prostate cancer eligible for active surveillance

Roberta Mazzucchelli, Andrea B enedetto Galosi, Antonio Lopez-Beltran, Marina Scarpelli, Liang Cheng, Rodolfo Montironi

Research output: Contribution to journalArticle

Abstract

Active surveillance (AS) is an important management option for men with lowrisk, clinically localized prostate cancer. The clinical parameters for patient selection and definition of progression for AS protocols are evolving as data from several large cohorts become mature. Vital to this process is the critical role pathologic parameters play in identifying appropriate candidates for AS. These findings need to be reproducible and accurately reported by pathologists. Repeated biopsy after initial diagnosis of prostate cancer is recommended before inclusion in active surveillance for early detection of significant cancer.

Original languageEnglish (US)
Pages (from-to)314-318
Number of pages5
JournalArchivio italiano di urologia, andrologia : organo ufficiale [di] Società italiana di ecografia urologica e nefrologica / Associazione ricerche in urologia
Volume86
Issue number4
DOIs
StatePublished - Dec 1 2014
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Biopsy
Early Detection of Cancer
Patient Selection
Pathologists

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pathological issues in biopsy specimens of men with prostate cancer eligible for active surveillance. / Mazzucchelli, Roberta; Galosi, Andrea B enedetto; Lopez-Beltran, Antonio; Scarpelli, Marina; Cheng, Liang; Montironi, Rodolfo.

In: Archivio italiano di urologia, andrologia : organo ufficiale [di] Società italiana di ecografia urologica e nefrologica / Associazione ricerche in urologia, Vol. 86, No. 4, 01.12.2014, p. 314-318.

Research output: Contribution to journalArticle

@article{42339afd94244d34a9a242703a9a2e7e,
title = "Pathological issues in biopsy specimens of men with prostate cancer eligible for active surveillance",
abstract = "Active surveillance (AS) is an important management option for men with lowrisk, clinically localized prostate cancer. The clinical parameters for patient selection and definition of progression for AS protocols are evolving as data from several large cohorts become mature. Vital to this process is the critical role pathologic parameters play in identifying appropriate candidates for AS. These findings need to be reproducible and accurately reported by pathologists. Repeated biopsy after initial diagnosis of prostate cancer is recommended before inclusion in active surveillance for early detection of significant cancer.",
author = "Roberta Mazzucchelli and Galosi, {Andrea B enedetto} and Antonio Lopez-Beltran and Marina Scarpelli and Liang Cheng and Rodolfo Montironi",
year = "2014",
month = "12",
day = "1",
doi = "10.4081/aiua.2014.4.314",
language = "English (US)",
volume = "86",
pages = "314--318",
journal = "Archivio Italiano di Urologia Andrologia",
issn = "1124-3562",
publisher = "Edizioni Scripta Manent s.n.c.",
number = "4",

}

TY - JOUR

T1 - Pathological issues in biopsy specimens of men with prostate cancer eligible for active surveillance

AU - Mazzucchelli, Roberta

AU - Galosi, Andrea B enedetto

AU - Lopez-Beltran, Antonio

AU - Scarpelli, Marina

AU - Cheng, Liang

AU - Montironi, Rodolfo

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Active surveillance (AS) is an important management option for men with lowrisk, clinically localized prostate cancer. The clinical parameters for patient selection and definition of progression for AS protocols are evolving as data from several large cohorts become mature. Vital to this process is the critical role pathologic parameters play in identifying appropriate candidates for AS. These findings need to be reproducible and accurately reported by pathologists. Repeated biopsy after initial diagnosis of prostate cancer is recommended before inclusion in active surveillance for early detection of significant cancer.

AB - Active surveillance (AS) is an important management option for men with lowrisk, clinically localized prostate cancer. The clinical parameters for patient selection and definition of progression for AS protocols are evolving as data from several large cohorts become mature. Vital to this process is the critical role pathologic parameters play in identifying appropriate candidates for AS. These findings need to be reproducible and accurately reported by pathologists. Repeated biopsy after initial diagnosis of prostate cancer is recommended before inclusion in active surveillance for early detection of significant cancer.

UR - http://www.scopus.com/inward/record.url?scp=84930169674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930169674&partnerID=8YFLogxK

U2 - 10.4081/aiua.2014.4.314

DO - 10.4081/aiua.2014.4.314

M3 - Article

VL - 86

SP - 314

EP - 318

JO - Archivio Italiano di Urologia Andrologia

JF - Archivio Italiano di Urologia Andrologia

SN - 1124-3562

IS - 4

ER -